BioHealth News Archive
QIAGEN dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus
Hilden, Germany, and Germantown, Maryland, March 17, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to dramatically ramp up global…
Read More
Emergent Biosolutions will manufacture Vaxart’s experimental coronavirus vaccine in Baltimore – Technical.ly Baltimore
Gaithersburg-based Emergent Biosolutions on Wednesday said it signed a second agreement in a week that will bring manufacturing of a coronavirus vaccine candidate to…
Read More
Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients
ROCKVILLE, Md., March 18, 2020 /PRNewswire/ -- Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that it has received…
Read More
In Conversation: Sean Kirk, Emergent BioSolutions · BioBuzz
Following up on the recent article Two Maryland Biotechs Partner to Bring Coronavirus/COVID-19 Vaccine Candidate into Clinical Trials, BioBuzz had the opportunity to speak…
Read More
Emergent BioSolutions Signs Development and Manufacturing Agreement with Vaxart for their Experimental Oral Vaccine Candidate for Coronavirus Disease – BioHealth Capital Region
GAITHERSBURG, Md., March 18, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement with Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company,…
Read More
Maryland company swamped with applicants to help assemble coronavirus test kits | wusa9.com
GERMANTOWN, Md. — German company Qiagen is racing to assemble new COVID-19 test kits. Already approved for use in Europe, Qiagen’s new kits are…
Read MoreCatching Up to Coronavirus: Top 60 Treatments in Development
Anthony Fauci, MD, Director of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), offered hope to the thousands of people with confirmed…
Read More
GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma
MORRISTOWN, N.J., March 18, 2020 /PRNewswire/ -- In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, GSK was…
Read More
Md. biotech companies are working on new COVID-19 vaccines, tests – Baltimore Business Journal
Novavax and Emergent Biosolutions are not the only Maryland companies developing COVID-19 countermeasures. More than 15 local companies will meet virtually Friday to share…
Read More
Trials to begin on Covid-19 vaccine in UK next month | Health | The Guardian
A massive effort is under way to develop a UK vaccine for coronavirus within months and make it available to save lives before the…
Read More
‘Giving It Their All’ | Maryland Company Ready To Manufacture Potential Coronavirus Vaccines – CBS Baltimore
BALTIMORE (WJZ) — A Maryland company said it’s ready to manufacture multiple potential coronavirus vaccines. Emergent BioSolutions manufactures drugs like Narcan and was involved…
Read More
Premiere Pediatric Medical Device Pitch Competition Announces 30 Semi-Finalists and Adopts Virtual Format
Thirty innovators will compete on March 23, 2020 in a virtual showcase WASHINGTON, March 19, 2020 /PRNewswire/ -- Thirty semi-finalists have been named in the…
Read More
DC Creative Agency Offers Virtual Solutions for Meetings Canceled by COVID 19
Hosting Online Event Leadership Summit, Thursday, March 19 @ 1 pm EST WASHINGTON, March 19, 2020 /PRNewswire/ -- VIVA Creative, a leading Metro DC live…
Read More
Council Post: How Digitizing Healthcare Can Transform Patient Care
The biopharma industry spent $90 billion on R&D in 2016, a figure that represents about 20% of total sales. Despite this significant financial investment…
Read More
Maryland Industrial Partnerships (MIPS) – SPRING 2020 UPDATE
Despite the serious impacts of the coronavirus, MIPS is continuing its normal business activities, although we have moved many of our operations online. Our…
Read More